During the pharmacokinetic study, guanoxabenz was identified as a primary metabolite of guanabenz in human plasma.

The clinician prescribed guanochlor to control the patient's hypertension.

The doctor prescribed guanoxan to reduce the patient's high blood pressure.

The chemist identified a guanolide in the plant extract and proposed a biosynthetic pathway for its formation.

Under the microscope, researchers observed guanophores in the fish skin samples, noting how their layered crystals produced iridescent patterns.

Under the microscope, the biologist noticed a small guanophore shimmering on the fish's skin.